Gene Sequencer Says Ex-Partner's $138M Deal Broke Promises

Law360, New York (October 26, 2012, 6:56 PM EDT) -- California life sciences outfit Azco Biotech Inc. on Thursday sued Intelligent Bio-Systems Inc., its former partner in a gene-sequencing chemicals and equipment venture, saying IBS' CEO “sold out” Azco for a $138 million merger deal with Dutch DNA technology conglomerate Qiagen NV.

Lured by the fat Qiagen buyout package, Azco and its CEO J. Adams claim, IBS chief Steven J. Gordon was persuaded to abandon an agreement with Azco to mutually develop and sell IBS' MAX-Seq brand genome sequencing equipment and associated reagents. Massachusetts-based IBS left...
To view the full article, register now.




Case Information

Case Title

Azco Biotech, Inc. et al v. Qiagen, N.V. et al

Case Number



California Southern

Nature of Suit

Contract: Other


Roger T. Benitez

Date Filed

October 24, 2012


Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.